These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5886538)

  • 21. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Simultaneous course of viral infections].
    Blagodatova NV
    Vopr Okhr Materin Det; 1966 Nov; 11(11):76. PubMed ID: 5998924
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined vaccine against measles, mumps, rubella and varicella and recommendations for varicella immunization in Italy?].
    Papa R; Spinelli R; Zaratti L; Franco E
    Ig Sanita Pubbl; 2007; 63(6):715-22. PubMed ID: 18216886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measles in viral hepatitis. (Clinical considerations)].
    Arditi E; Rossetto S
    G Mal Infett Parassit; 1967 Jun; 19(6):371-2. PubMed ID: 6051988
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunohistochemical study of cellular events in lesional skin during common virus infections.
    Tsukahara T; Horiuchi Y
    J Dermatol; 1996 Jan; 23(1):22-32. PubMed ID: 8720254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.
    Nokes DJ; Enquselassie F; Nigatu W; Vyse AJ; Cohen BJ; Brown DW; Cutts FT
    Bull World Health Organ; 2001; 79(7):588-95. PubMed ID: 11477961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of antibodies to measles and rubella in Sana'a, Yemen.
    Sallam TA; Al-Jaufy AY; Al-Shaibany KS; Ghauth AB; Best JM
    Vaccine; 2006 Sep; 24(37-39):6304-8. PubMed ID: 16815602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Varicella inclusion bodies in an odontogenic cyst.
    Goldberg M; Beckett R; Yaghmayi M; Segal D
    J Conn State Dent Assoc; 1983 Aug; 57(3):122-4. PubMed ID: 6311880
    [No Abstract]   [Full Text] [Related]  

  • 32. [Skin eruptions in children].
    Gaudelus J
    Rev Prat; 2004 Jun; 54(12):1343-50. PubMed ID: 15461055
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
    Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the course of pediatric droplet infections in adults].
    Koriagin VN
    Klin Med (Mosk); 1982; 60(8):76-80. PubMed ID: 7144087
    [No Abstract]   [Full Text] [Related]  

  • 35. [Standardization of neutralization tests using the COBL cell line and comparison with the particle agglutination test for measles serology].
    Korukluoğlu G; Yalçinkaya T; Ozkaya E; Kurtoğlu D; Gözalan A; Miyamura K
    Mikrobiyol Bul; 2002 Apr; 36(2):193-9. PubMed ID: 12652872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults].
    Garrido Redondo M; Blanco Quirós A; Garrote Adrados JA; Tellería Orriols JJ; Arranz Sanz E
    An Esp Pediatr; 1997 Nov; 47(5):499-504. PubMed ID: 9586291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 38. A concise review: common viral exanthems and enanthems.
    Behbehani AM
    J Kans Med Soc; 1981 Oct; 82(10):442-6. PubMed ID: 6278035
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.